We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOX icon
376
Box
BOX
$4.49B
– –
-9,651
Closed -$247K
CIM
377
Chimera Investment
CIM
$1.06B
– –
-6,402
Closed -$95.8K
CTRE icon
378
CareTrust REIT
CTRE
$10B
– –
-14,554
Closed -$326K
D icon
379
Dominion Energy
D
$62.1B
– –
-4,495
Closed -$211K
DVA icon
380
DaVita
DVA
$15.5B
– –
-3,201
Closed -$335K
DXCM icon
381
DexCom
DXCM
$29B
– –
-3,640
Closed -$452K
EEFT icon
382
Euronet Worldwide
EEFT
$3.19B
– –
-3,817
Closed -$387K
FMC icon
383
FMC
FMC
$1.25B
– –
-5,500
Closed -$347K
FWRD icon
384
Forward Air
FWRD
$461M
– –
-3,294
Closed -$207K
GERN icon
385
Geron
GERN
$898M
– –
-35,675
Closed -$75.3K
HBAN icon
386
Huntington Bancshares
HBAN
$34B
– –
-14,701
Closed -$187K
HNRG icon
387
Hallador Energy
HNRG
$646M
– –
-28,506
Closed -$252K
HPE icon
388
Hewlett Packard
HPE
$58.8B
– –
-12,031
Closed -$204K
HSTM icon
389
HealthStream
HSTM
$863M
– –
-15,785
Closed -$427K
IDCC icon
390
InterDigital
IDCC
$6.75B
– –
-3,709
Closed -$403K
IPG
391
DELISTED
Interpublic Group of Companies
IPG
– –
-9,324
Closed -$304K
JNJ icon
392
Johnson & Johnson
JNJ
$640B
– –
-3,254
Closed -$510K
JNPR
393
DELISTED
Juniper Networks
JNPR
– –
-14,540
Closed -$429K
OPLN
394
Openlane
OPLN
$4.28B
– –
-10,340
Closed -$153K
KIDS icon
395
OrthoPediatrics
KIDS
$513M
– –
-6,200
Closed -$202K
KWR icon
396
Quaker Houghton
KWR
$2.58B
– –
-1,434
Closed -$306K
LMT icon
397
Lockheed Martin
LMT
$131B
– –
-558
Closed -$253K
LXRX icon
398
Lexicon Pharmaceuticals
LXRX
$1.03B
– –
-103,144
Closed -$158K
MCS icon
399
Marcus Corp
MCS
$767M
– –
-26,530
Closed -$387K
MDGL icon
400
Madrigal Pharmaceuticals
MDGL
$12.6B
– –
-1,247
Closed -$289K
14 15
16
17 18

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.